Treatment of community-acquired pneumonia - IDSA guidelines

Chest

Volumn 115, Issue 3 SUPPL., 1999, Pages 9S-13S

  Bernstein, Jack M ^a,b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

American Thoracic Society guidelines; Antibiotics; Community acquired pneumonia; Empiric therapy; Etiology; Infectious Diseases Society of America guidelines

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DOXYCYCLINE; MACROLIDE; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ASPIRATION PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; DRUG CHOICE; HOSPITALIZATION; HUMAN; INFECTIOUS PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; LEGIONELLA PNEUMOPHILA; MEDICAL SOCIETY; ORAL DRUG ADMINISTRATION; PENICILLIN ALLERGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; UNITED STATES;

EID: 0033037090     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.suppl_1.9S     Document Type: Article

References (16)

1. US Dept of Commerce Bureau of the Census. Monthly vital statistics report. 1997; 45:21-24
2. CDC. Pneumonia and influenza death rates - United States, 1979-1994. MMWR 1994; 44:535-537
3. Ely EW. Pneumonia in the elderly: diagnostic and therapeutic challenges. Infect Med 1997; 14:643-654
4. Segreti J. Community-acquired pneumonia: new pathogens, new resistance patterns. Infect Med 1996; 13(suppl A):9-14
5. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Am J Med 1985; 78(suppl 6B):32-37
6. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994; 18:501-515
7. Niederman MS, Bass JB Jr. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy: American Thoracic Society: Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 148: 1418-1426
8. Mandell LA, Niederman M. The Canadian community-acquired pneumonia consensus conference group. Can J Infect Dis 1993; 4:25-28
9. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101:1005-1012
10. Gotfried M. CAP guidelines of the American Thoracic Society. Infect Med 1996; 13(suppl A):15-21
11. Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26:811-838
12. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991; 115:428-436
13. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network. The emerging infections network: a new venture for the Infectious Diseases Society of America. Clin Infect Dis 1997; 25:34-36
14. Ramirez JA, Srinath L, Ahkee S, et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med 1995; 155:1273-1276
15. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
16. Marston BJ, Plouffe JF, File TM Jr. et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157:1709-1718